255 related articles for article (PubMed ID: 31865400)
1. The effect of antibiotics on clinical outcomes in immune-checkpoint blockade: a systematic review and meta-analysis of observational studies.
Wilson BE; Routy B; Nagrial A; Chin VT
Cancer Immunol Immunother; 2020 Mar; 69(3):343-354. PubMed ID: 31865400
[TBL] [Abstract][Full Text] [Related]
2. Association of antibiotic treatment with survival outcomes in treatment-naïve melanoma patients receiving immune checkpoint blockade.
Chorti E; Kowall B; Hassel JC; Schilling B; Sachse M; Gutzmer R; Loquai C; Kähler KC; Hüsing A; Gilde C; Thielmann CM; Zaremba-Montenari A; Placke JM; Gratsias E; Martaki A; Roesch A; Ugurel S; Schadendorf D; Livingstone E; Stang A; Zimmer L
Eur J Cancer; 2024 Mar; 200():113536. PubMed ID: 38306840
[TBL] [Abstract][Full Text] [Related]
3. NSCLC Immunotherapy Efficacy and Antibiotic Use: A Systematic Review and Meta-Analysis.
Lurienne L; Cervesi J; Duhalde L; de Gunzburg J; Andremont A; Zalcman G; Buffet R; Bandinelli PA
J Thorac Oncol; 2020 Jul; 15(7):1147-1159. PubMed ID: 32173463
[TBL] [Abstract][Full Text] [Related]
4. The impact of antibiotics on efficacy of immune checkpoint inhibitors in malignancies: A study based on 44 cohorts.
Wu Q; Liu J; Wu S; Xie X
Int Immunopharmacol; 2021 Mar; 92():107303. PubMed ID: 33465728
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of antibiotic exposure association with clinical outcomes of chemotherapy versus immunotherapy across three tumour types.
Kulkarni AA; Ebadi M; Zhang S; Meybodi MA; Ali AM; DeFor T; Shanley R; Weisdorf D; Ryan C; Vasu S; Rashidi A; Patel MR
ESMO Open; 2020 Sep; 5(5):e000803. PubMed ID: 32900789
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic exposure windows and the efficacy of immune checkpoint blockers in patients with cancer: a meta-analysis.
Huang L; Chen X; Zhou L; Xu Q; Xie J; Zhan P; Lv T; Song Y
Ann Palliat Med; 2021 Mar; 10(3):2709-2722. PubMed ID: 33549013
[TBL] [Abstract][Full Text] [Related]
7. Effects of Antibiotic Use on Outcomes in Cancer Patients Treated Using Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
Yu Y; Zheng P; Gao L; Li H; Tao P; Wang D; Ding F; Shi Q; Chen H
J Immunother; 2021 Feb-Mar 01; 44(2):76-85. PubMed ID: 33208635
[TBL] [Abstract][Full Text] [Related]
8. Impact of Use of Antibiotics on Response to Immune Checkpoint Inhibitors and Tumor Microenvironment.
Khan U; Ho K; Hwang EK; Peña C; Brouwer J; Hoffman K; Betel D; Sonnenberg GF; Faltas B; Saxena A; Weisiger KE; Oh S; Hissong E; RoyChoudhury A; Shah MA
Am J Clin Oncol; 2021 Jun; 44(6):247-253. PubMed ID: 33826550
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of classical clinical endpoints as surrogates for overall survival in patients treated with immune checkpoint blockers: a systematic review and meta-analysis.
Kaufman HL; Schwartz LH; William WN; Sznol M; Fahrbach K; Xu Y; Masson E; Vergara-Silva A
J Cancer Res Clin Oncol; 2018 Nov; 144(11):2245-2261. PubMed ID: 30132118
[TBL] [Abstract][Full Text] [Related]
10. Use of antibiotics is associated with worse clinical outcomes in patients with cancer treated with immune checkpoint inhibitors: A systematic review and meta-analysis.
Tsikala-Vafea M; Belani N; Vieira K; Khan H; Farmakiotis D
Int J Infect Dis; 2021 May; 106():142-154. PubMed ID: 33771672
[TBL] [Abstract][Full Text] [Related]
11. The association between antibiotics use and outcome of cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.
Xu H; Xu X; Wang H; Ge W; Cao D
Crit Rev Oncol Hematol; 2020 May; 149():102909. PubMed ID: 32146284
[TBL] [Abstract][Full Text] [Related]
12. The negative effect of antibiotics on RCC patients with immunotherapy: A systematic review and meta-analysis.
Luo Z; Hao S; Li Y; Cheng L; Zhou X; Gunes EG; Liu S; Chen J
Front Immunol; 2022; 13():1065004. PubMed ID: 36505435
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous transhepatic cholangial drainage or antibiotic therapy worsens response to immunotherapy in advanced cholangiocarcinoma.
Huang Q; Wang F; Zhang X; Liu J; Dou X; Feng R; Zhu K; Jiang S; Zhang Y; Yue J
BMC Cancer; 2023 Jul; 23(1):657. PubMed ID: 37442960
[TBL] [Abstract][Full Text] [Related]
14. Cumulative Antibiotic Use Significantly Decreases Efficacy of Checkpoint Inhibitors in Patients with Advanced Cancer.
Tinsley N; Zhou C; Tan G; Rack S; Lorigan P; Blackhall F; Krebs M; Carter L; Thistlethwaite F; Graham D; Cook N
Oncologist; 2020 Jan; 25(1):55-63. PubMed ID: 31292268
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic use reduces the efficacy of immune checkpoint inhibitors in patients with urothelial carcinoma: A systematic review and meta-analysis.
Febriyanto T; Muhammad F; Wijaya W; Oey O; Simadibrata DM
Urol Oncol; 2024 May; 42(5):160.e11-160.e23. PubMed ID: 38101990
[TBL] [Abstract][Full Text] [Related]
16. Impact of antibiotic treatment on immune-checkpoint blockade efficacy in advanced non-squamous non-small cell lung cancer.
Huemer F; Rinnerthaler G; Westphal T; Hackl H; Hutarew G; Gampenrieder SP; Weiss L; Greil R
Oncotarget; 2018 Mar; 9(23):16512-16520. PubMed ID: 29662663
[TBL] [Abstract][Full Text] [Related]
17. The effect of antibiotics on the clinical outcomes of patients with solid cancers undergoing immune checkpoint inhibitor treatment: a retrospective study.
Kim H; Lee JE; Hong SH; Lee MA; Kang JH; Kim IH
BMC Cancer; 2019 Nov; 19(1):1100. PubMed ID: 31718585
[TBL] [Abstract][Full Text] [Related]
18. Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis.
Conforti F; Pala L; Bagnardi V; De Pas T; Martinetti M; Viale G; Gelber RD; Goldhirsch A
Lancet Oncol; 2018 Jun; 19(6):737-746. PubMed ID: 29778737
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic administration shortly before or after immunotherapy initiation is correlated with poor prognosis in solid cancer patients: An up-to-date systematic review and meta-analysis.
Yang M; Wang Y; Yuan M; Tao M; Kong C; Li H; Tong J; Zhu H; Yan X
Int Immunopharmacol; 2020 Nov; 88():106876. PubMed ID: 32799113
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Tumor Vaccines and Cellular Immunotherapies in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Dammeijer F; Lievense LA; Veerman GD; Hoogsteden HC; Hegmans JP; Arends LR; Aerts JG
J Clin Oncol; 2016 Sep; 34(26):3204-12. PubMed ID: 27432922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]